ARUP's Laboratory Test Directory contains complete, up-to-date test information, including methodology and reporting times, collection and transportation specifications, reference intervals, test notes, and CPT codes. Clients can access entries via an A to Z index and search by test name, key word, test number, or mnemonic.
The * wildcard is used to search for many letters within a word and can be used when the spelling, suffix, or prefix of the search term are in question: e.g., manage* = management, manages, managed, manager, etc.; d*ing = divorcing, dividing, droning, etc.
The ? wildcard is used to search for a single letter within a word and can be used when the spelling of the search term is in question: e.g., h?t = hat, hit, hot, etc. (but will NOT find heat).
Test Entry Updates
The redesigned test entries are cleaner and easier to use, and include two new sections.
Find out more.
NanoString Technologies Announces the Prosigna Breast Cancer Assay Will Be Performed at ARUP
The Prosigna assay provides a risk category and numerical score to assess the risk of disease recurrence at 10 years in postmenopausal women with node-negative or node-positive, hormone receptor-positive breast cancer.
Read the press release.
ARUP Offers Infliximab Activity and Neutralizing Antibody Test
Serum levels of infliximab (Remicade) and anti-infliximab antibodies are measured. This is the only clinical test that measures bioactivity of infliximab to aid in the management of patients with chronic inflammatory disease.
Learn more about our methodology.
New and Improved Testing for Leukemia/Lymphoma Phenotyping
Beginning May 20, 2013, ARUP will change the way many of the tests currently offered for leukemia/lymphoma phenotyping are handled and reported. These changes will allow ARUP to better tailor testing for each patient. They will also allow greater flexibility in performing and billing for individual markers.